期刊文献+

结直肠癌肝转移的有效治疗策略 被引量:1

Effective treatment strategies for colorectal liver metastases
原文传递
导出
摘要 结直肠癌是一种常见的恶性肿瘤,较容易发生肝转移,目前手术联合全身化疗是结直肠癌肝转移的主要治疗手段,本文主要从术前化疗、手术方式选择和局部治疗等方面来讨论能使患者获益最大化的治疗策略。 Colorectal cancer is a common malignancy and frequently has manifest with liver metastases. Surgery, in conjunction with systemic chemotherapy are the primary treatment at present. This article discussed the treatment strategies mainly from the aspects of preoperative chemotherapy, selection of operative procedures and local treatment and found the strategy which could benefit patients most.
出处 《中华临床医师杂志(电子版)》 CAS 2014年第23期109-115,共7页 Chinese Journal of Clinicians(Electronic Edition)
关键词 结直肠肿瘤 肿瘤转移 Colorectal neoplasms Neoplasm metastasis
  • 相关文献

参考文献40

  • 1Ferlay J,Shin HR,Bray F,et al.Estimates of worldwide burden of cancer in 2008:GLOBOCAN2008[J].Int J Cancer,2010,127(2):2893-2917.
  • 2Kemeny N.Presurgical chemotherapy in patients being considered for liver resection[J].The Oncologist,2007,12(7):825-839.
  • 3Khatri VP,Chee KG,Petrelli NJ.Modern multimodality approach to hepatic colorectal metastases:solutions and controversies[J].Surg Oncol,2007,16(1):71-83.
  • 4Nordlinger B,Sorbye H,Glimelius B,et al.Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer(EORTC Intergroup trial 40983):A randomised controlled trial[J].Lancet,2008,371(9617):1007-1016.
  • 5Nordlinger B,Sorbye H,Glimelius B,et al.Perioperative FOLFOX4Chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer(EORTC40983):long-term results of a randomize,controlled,phase 3 trial[J].Lancet Oncol,2013,14(12):1208-1215.
  • 6Adam R,Pascal G,Castaing D,et al.Tumor progression while on chemotherapy:A contraindication to liver resection for multiple colorectal metastases?[J].Ann Surg,2004,240(6):1052-1061.
  • 7Tamandl D,Gruenberger B,Herberger,et al.Surgery after neoadjuvant chemotherapy for colorectal liver metastases is safe and feasible in elderly patients[J].J Surg Oncol,2009,100(5):364-371.
  • 8Gruenberger B,Scheithauer W,Punzengruber R,et al.Importance of response to neoadjuvant chemotherapy in potentially potentially curable colorectal cancer liver metastases[J].BMC Cancer,2008,8:120.
  • 9Folprecht G,Grothey A,Alberts S,et al.Neoadjuvant treatment of unresectable colorectal liver metastases:Correlation between tumour response and resection rates[J].Ann Oncol,2005,16(8):1311-1319.
  • 10Hind D,Tappenden P,Tumur I,et al.The use of irinotecan,oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer:systematic review and economic evaluation[J].Health Technol Assess,2008,12(15):iii-ix,xi-162.

二级参考文献20

  • 1Aliki Taylor,Primrose,Gena Kanas,Graeme Poston,Michael Choti,Dominik Alexander,Fionna Mowat,Kelsh,Wendy Langeberg.Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors[J]. Clinical Epidemiology . 2012 (Issue 1)
  • 2Min-Shan Chen,Jin-Qing Li,Yun Zheng,Rong-Ping Guo,Hui-Hong Liang,Ya-Qi Zhang,Xiao-Jun Lin,Wan Y. Lau.A Prospective Randomized Trial Comparing Percutaneous Local Ablative Therapy and Partial Hepatectomy for Small Hepatocellular Carcinoma[J]. Annals of Surgery . 2006 (3)
  • 3Suzanne Claire Schiffman,Matthew Bower,Russell E. Brown,Robert C. G. Martin,Kelly M. McMasters,Charles R. Scoggins.Hepatectomy is Superior to Thermal Ablation for Patients with a Solitary Colorectal Liver Metastasis[J].Journal of Gastrointestinal Surgery.2010(12)
  • 4Gerd Otto,Christoph Düber,Maria Hoppe-Lotichius,Jochem K?nig,Michael Heise,Michael Bernhard Pitton.Radiofrequency Ablation as First-Line Treatment in Patients With Early Colorectal Liver Metastases Amenable to Surgery[J].Annals of Surgery.2010(5)
  • 5Hyuk Hur,Yong Taek Ko,Byung Soh Min,Kyung Sik Kim,Jin Sub Choi,Seung Kook Sohn,Chang Hwan Cho,Heung Kyu Ko,Jong Tai Lee,Nam Kyu Kim.Comparative study of resection and radiofrequency ablation in the treatment of solitary colorectal liver metastases[J].The American Journal of Surgery.2009(6)
  • 6Nathaniel P. Reuter,Charles E. Woodall,Charles R. Scoggins,Kelly M. McMasters,Robert C. G. Martin.Radiofrequency Ablation vs. Resection for Hepatic Colorectal Metastasis: Therapeutically Equivalent?[J].Journal of Gastrointestinal Surgery.2009(3)
  • 7R. R. White,I. Avital,C. T. Sofocleous,K. T. Brown,L. A. Brody,A. Covey,G. I. Getrajdman,W. R. Jarnagin,R. P. Dematteo,Y. Fong,L. H. Blumgart,M. D’Angelica.Rates and Patterns of Recurrence for Percutaneous Radiofrequency Ablation and Open Wedge Resection for Solitary Colorectal Liver Metastasis[J].Journal of Gastrointestinal Surgery.2007(3)
  • 8A.McKay,E.Dixon,M.Taylor.Current role of radiofrequency ablation for the treatment of colorectal liver metastases[J].Br J Surg.2006(10)
  • 9Eddie K. Abdalla,Jean-Nicolas Vauthey,Lee M. Ellis,Vickie Ellis,Raphael Pollock,Kristine R. Broglio,Kenneth Hess,Steven A. Curley.Recurrence and Outcomes Following Hepatic Resection, Radiofrequency Ablation, and Combined Resection/Ablation for Colorectal Liver Metastases[J].Annals of Surgery.2004(6)
  • 10A.Oshowo,A.Gillams,E.Harrison,W. R.Lees,I.Taylor.Comparison of resection and radiofrequency ablation for treatment of solitary colorectal liver metastases[J].Br J Surg.2003(10)

共引文献11

同被引文献10

  • 1Rastogi T, Hildesheim A, Sinha R. Opportunities for cancer epidemiolo- gy in developing countries[ J]. Nat Rev Cancer,200d ,4( 11 ) :909-917.
  • 2de Jong MC, Pulitano C, Ribero D, et al. Rates and patterns of recur- rence following curative intent surgery for colorectal liver metastasis:an international multi-institutional analysis of 1669 patients [ J ]. Ann Surg ,2009,250 ( 3 ) :440-448.
  • 3Vigan6 L, Ferrero A, Lo Tesoriere R, et al. Liver surgery for colorectal metastases :results after 10 years of follow-up. Long-term survivors,late recurrences, and prognostic role of morbidity [ J ]. Ann Surg Oncol, 2008,15 (9) :2458-2464.
  • 4Takahashi S, Konishi M, Nakagohri T, et al. Short time to recurrence af- ter hepatic resection correlates with poor prognosis in eolorectal hepatic metastasis[J]. Jpn J Clin Oneol,2006,36(6) :368-375.
  • 5Yamashita Y, Adachi E, Tab Y, et al. Risk factors for early recurrence after curative hepateetamy for colorectal liver metastases [ J 1- Surg To- day,2011,41 (4) :526-532.
  • 6Vigan6 L, Capussotti L, Lapointe R, et al. Early recurrence after liver resection for colorectal metastases: risk factors, prognosis, and treat- ment. A l,iverMetSurvey-based study of 6,025 patients [ J ]. Ann Surg 0ncol,2014,21 (4) :1276-1286.
  • 7Nordlinger B, Sorbye H, Glimelius B, et al. Pefioperative FOLFOX4 Chemotherapy and surgery versus surgery alone for resectable liver me- tastases from colorectal cancer (EORTC40983) :long-term results of a randomize, controlled, phase 3 trial [ J ]. Lancet Oncol, 2013,14 ( 12 ) : 1208-1215.
  • 8Ribero D ,Viganb L,Amisano M ,et al. Prognostic factors after resection of colorectal liver metastases : from morphology to biology [ J ]. Future Onco1,2013,9( 1 ) :45-57.
  • 9Gruenberger B, Scheithauer W,Punzengruber R, et al. Importance of re- sponse to neoadjuvant chemotherapy in potentially potentially curable colorectal cancer liver metastases [ J J. BMC Cancer, 2008,8 ( 120 ) : 1- 7.
  • 10Tamandl D, Gruenberger B, Herberger B, et al. Surgery ~ter neoadju- rant chemotherapy for colorectal liver metastases is safe and feasible in elderly patients[ J]. J Surg Onco1,2009,1(~0(5 ) :364-371.

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部